Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
Clinical trial NCT06528691 · RECRUITING
Trial details
- NCT number
- NCT06528691
- Sponsor
- St. Jude Children's Research Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2027-11-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.